ZIOPHARM initiates ZIN ATI-001 Phase 1 clinical study in advanced melanoma

[News]

ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.

More... (http://www.news-medical.net/news/20110830/ZIOPHARM-initiates-ZIN-ATI-001-Phase-1-clinical-study-in-advanced-melanoma.aspx)